NCT05833217
- Conditions
- COVID-19, Chronic Disease, Coronaviridae Infections, +22 more
- Locations
-
- Clinical and Translational Research Unit Palo Alto, California, United States
- Stanford Health Palo Alto, California, United States
Clinical trial condition
Explore clinical trials studying Glucose Metabolism Disorders. Study availability and eligibility vary by location and protocol.
NCT05833217
NCT05165706
NCT05767450
NCT05957055
NCT06591286
NCT06708780
NCT06704321
NCT06360302
NCT06703788
NCT06435598